Endoscopic Ultrasound Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Needle, Endoscope), By Application (Gastrointestinal Cancer, Lung Cancer), By End Use (ASCs, Hospitals), By Region, And Segment Forecasts

Endoscopic Ultrasound Market Summary

The global endoscopic ultrasound market size was estimated at USD 1.53 billion in 2024 and is projected to reach USD 2.27 billion by 2030, growing at a CAGR of 6.85% from 2025 to 2030. The market growth is driveb by various factors, such as the rising prevalence of gastrointestinal cancer, technological advancements, and increasing instances of pancreaticobiliary malignancies.

For instance, as per the American Cancer Society’s estimates for 2023, about 64,050 new cases of pancreatic cancer will be diagnosed in the U.S., and around 50,550 deaths are expected due to pancreatic cancer. Lung cancer is the major cause of cancer deaths worldwide; according to the Lung Cancer Research Foundation, 1 in 16 people will be diagnosed with lung cancer in their lifespan.

As reported by Cancer.Net in March 2023, about 238,340 new lung cancer cases were diagnosed in the U.S., while globally, around 2,206,771 individuals were diagnosed with lung cancer in 2020. Colorectal cancer (CRC) is the second-leading cause of cancer deaths worldwide; according to the American Cancer Society, nearly 153,020 new CRC cases are anticipated in the U.S. for 2023, resulting in approximately 52,550 deaths. These figures underscore the potential for market growth during the forecast period, and together with increasing investments in endoscopic ultrasound research and development, they are expected to propel market expansion in the upcoming years.

Similarly, an article published by NIH in June 2023 reported that, according to the American Society for Gastrointestinal Endoscopy, a new ultrasound capsule endoscopy (USCE) combining white light and ultrasound imaging has been developed for superficial and submucosal imaging of the esophagus. In addition, various interventional endoscopic ultrasound devices, such as puncture needles, guidewires, tract dilation devices, stents, and troubleshooting tools, have been introduced. Moreover, increasing R&D efforts in advanced endoscopic ultrasound (EUS) technologies by major companies are expected to propel market growth; for instance, in October 2022, Olympus launched the EU-ME3 endoscopic ultrasound processor platform, enhancing diagnostics for pancreatitis, pancreatic cancer, and stomach and esophageal cancer invasion detection.

Market Concentration & Characteristics

The industry is in a medium growth stage, with an accelerating pace of expansion. The endoscopic ultrasound industry is driven by the rising prevalence of gastrointestinal and pancreatic disorders, technological advancements, and a growing preference for minimally invasive procedures. In addition, the increasing geriatric population and rising global healthcare spending are anticipated to fuel market growth further throughout the forecast period.

The endoscopic ultrasound industry is experiencing substantial innovations as industry leaders unveil advanced systems and products to cater to the growing demand and enhance patient outcomes. For example, in March 2025, FUJIFILM Healthcare Europe introduced the EG-740UT Interventional Ultrasonic Endoscope across Europe. This cutting-edge device incorporates miniaturized single-crystal technology, offering improved imaging quality characterized by reduced noise and increased resolution. Aimed at therapeutic applications, it features a 4.0 mm working channel and enhanced maneuverability, which reduces blind spots during procedures. Furthermore, the endoscope is designed to work with sophisticated imaging techniques like Detective Flow Imaging and Contrast Harmonic Imaging, showcasing its superior diagnostic capabilities.

The endoscopic ultrasound industry is expected to witness significant partnership and collaboration activities from companies to enhance technological innovation and expand their market presence. For instance, in January 2024, Canon Medical Systems Corporation and Olympus Corporation announced a collaboration on Endoscopic Ultrasound Systems (EUS). Canon Medical develops and manufactures diagnostic ultrasound systems for EUS, leveraging technologies such as Aplio i800, while Olympus manages sales and marketing using its Ultrasound Endoscopes. This partnership aims to deliver advanced EUS equipment offering high-quality image diagnoses and enhanced diagnostic performance, contributing to early disease detection and minimally invasive treatment.

Regulations play a pivotal role in shaping the growth and innovation landscape of the endoscopic ultrasound industry. Regulatory frameworks, including device approvals, safety standards, and reimbursement policies, directly impact manufacturers’ ability to bring new products to market and influence clinicians’ adoption rates. Stringent approval processes by agencies such as the FDA or EMA ensure patient safety, extend product development timelines, and increase costs, which may restrain smaller companies or startups from entering the market. However, well-structured regulatory pathways and faster approval mechanisms, such as breakthrough device designations, can accelerate innovation and competitive dynamics.

The threat of substitutes in the endoscopic ultrasound industry is moderate. Key substitutes include advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), which can offer non-invasive diagnostic capabilities for many of the same indications as endoscopic ultrasound (EUS), including gastrointestinal and pancreatic diseases. However, despite these alternatives, EUS retains a strong position due to its unique ability to combine high-resolution imaging with fine-needle aspiration or biopsy, enabling diagnostic and therapeutic interventions in a single procedure.

The endoscopic ultrasound industry's regional expansion is driven by rising disease prevalence, technological innovation, and increasing healthcare investments across emerging economies. This expansion is also driven by the companies’ strategic efforts to diversify their market presence, reduce dependence on mature regions, and tap into new growth opportunities. Manufacturers focus on strengthening local distribution networks, establishing partnerships with healthcare providers, and investing in training programs to enhance procedural adoption. In addition, the shift toward value-based care and the growing emphasis on early disease detection fuel demand for EUS across both developed and developing markets.

Product Insights

The endoscope segment led the market with the largest revenue share of about 33.84% in 2024. This growth can be linked to the increasing number of echo-endoscopy procedures, heightened awareness of the advantages of early disease detection, and improvements in endoscope technology. For example, in May 2023, Olympus Corp. gained FDA approval for the EVIS X1 endoscopy system, alongside two gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope and the CF-HQ1100DL/I colonovideoscope. Healthcare professionals utilize Olympus GI endoscopy instruments to diagnose, treat, and monitor conditions affecting the upper and lower GI tract, including acid reflux, ulcers, Crohn's disease, celiac disease, and colon cancer.

The needle segment will register the fastest CAGR of 8.1% from 2025 to 2030. Needles are typically employed to collect tissue samples from various gastrointestinal organs and lesions, including the pancreas, liver, lymph nodes, and GI wall. Moreover, fine-needle aspiration of lymph nodes and nearby structures assists in accurately staging tumors. The growing incidence of gastrointestinal diseases is also anticipated to drive market expansion. For instance, according to the American Cancer Society Journal, as of January 2023, approximately 21,560 new esophageal cancer cases and 26,500 stomach cancer cases were estimated in the U.S.

Application Insights

Based on application, the lung cancer segment led the market with a 42.18% revenue share in 2024. The increasing incidence of lung cancer is the key factor driving market expansion. According to the American Cancer Society, approximately 21,560 new lung cancer cases are expected to be diagnosed in the U.S. in 2023. Lung cancer may develop due to multiple factors, including tobacco use, prior radiation exposure, and contact with radon gases. As reported by the Centers for Disease Control and Prevention in May 2023, about 28.3 million U.S. adults smoked cigarettes, roughly 3.08 million middle and high school students in the U.S. use at least one tobacco product, including e-cigarettes, and nearly 1,600 U.S. youth try their first cigarette every day. Each year, almost 500,000 individuals in the U.S. die prematurely due to smoking or exposure to second-hand smoke. In addition, around 16 million people are living with serious health conditions caused by smoking.

The gastrointestinal cancer segment is projected to register the fastest CAGR of 7.7% from 2025 to 2030. The rising prevalence of gastrointestinal cancer is expected to propel market growth. Cancers of the GI tract encompass anal cancer, bile duct cancer, colon cancer, esophageal cancer, gallbladder cancer, liver cancer, rectal cancer, gastrointestinal stromal tumors, small intestine cancer, and stomach cancer. For example, the American Cancer Society Journal from January 2023 forecasts approximately 348,840 new cases of digestive system cancer in the U.S. for 2023. Each year, stomach cancer accounts for 1.5% of all new cancer cases in the U.S. Most stomach cancer diagnoses occur in older adults, typically those aged 68 and above. Annually, 60% of stomach cancer cases are found in patients aged 65 and older. The lifetime risk of developing stomach cancer is higher for men (about 1 in 96) compared to women (approximately 1 in 152).

End Use Insights

The hospital segment held the largest market share in 2024. This expansion is driven by favourable health reimbursement for minimally invasive procedures, well-developed healthcare infrastructure, and a growing number of skilled and qualified endoscopists. For example, according to the American Hospital Association, there were 6,129 hospitals in the U.S. as of May 2023. In addition, the increasing geriatric population is anticipated to propel the growth of the hospital segment, as most hospital admissions in the United States involve individuals aged 65 years and older. 

The ambulatory surgical center segment is projected to register the fastest CAGR from 2025 to 2030. The rising prevalence of gastrointestinal disorders, including esophageal cancer, stomach (gastric) cancer, colorectal cancer, liver cancer, and pancreaticobiliary conditions, such as gallbladder, pancreas, and bile duct diseases, is anticipated to drive segment expansion. For instance, according to Cancer.Net, around 26,500 new cases of stomach cancer are expected to be diagnosed in the U.S. Furthermore, ASCs offer patients a more convenient and comfortable setting, which can result in higher patient satisfaction and growing demand for EUS procedures.

Regional Insights

The endoscopic ultrasound industry in North America dominated the global market and accounted for a revenue share of 31.0% in 2024. Rising R&D investments by the government and leading regional companies, advanced healthcare infrastructure, and progress in endoscopic ultrasound technology are driving growth in North America. For instance, in July 2023, Cook Medical introduced the EchoTip ProCore. This high-resolution ultrasound biopsy needle enables clinicians to obtain larger tissue samples from hard-to-reach areas through minimally invasive endoscopic ultrasound procedures.

U.S. Endoscopic Ultrasound Market Trends

The endoscopic ultrasound industry in the U.S. is being driven by rising demand for minimally invasive diagnostic and therapeutic procedures for gastrointestinal and pancreatic diseases. The increasing incidence of gastrointestinal cancers, coupled with the growing elderly population, is fueling the adoption of EUS, as it offers superior accuracy over conventional imaging techniques. The rising awareness among healthcare professionals and patients about early cancer detection also contributes to the increasing demand.

Europe Endoscopic Ultrasound Market Trends

The endoscopic ultrasound industry in Europe is driven by increasing demand for diagnostic procedures for minimally invasive gastrointestinal (GI) and pancreatic diseases. Countries such as Germany, the UK, and France are at the forefront of this expansion, where high standards of healthcare infrastructure and advanced medical technologies support the widespread adoption of endoscopic ultrasounds. In addition, the regulatory environment in Europe is conducive to integrating advanced imaging technologies, which helps enhance diagnostic accuracy, particularly in oncology and gastroenterology.

The endoscopic ultrasound industry in the UK has witnessed significant growth, fueled by the increasing prevalence of gastrointestinal cancers, such as pancreatic and esophageal cancers. Endoscopic ultrasound offers superior imaging capabilities, enabling early detection and precise staging of these cancers, which is crucial for effective treatment planning. In addition, the UK's aging population contributes to a higher incidence of gastrointestinal disorders, further increasing the demand for EUS procedures.

Germany endoscopic ultrasound industry has witnessed significant growth in the European market, driven by strong healthcare infrastructure, high disease burden, and continuous innovation. Germany’s well-developed network of hospitals and specialized medical centers ensures that advanced diagnostic tools such as EUS are widely available and integrated into routine clinical practice.

Asia Pacific Endoscopic Ultrasound Market Trends

The endoscopic ultrasound industry in Asia Pacific is expected to witness the fastest CAGR over the forecast period, fueled by the rising prevalence of gastrointestinal disorders and cancers, particularly in countries such as China, Japan, and South Korea. Rapid urbanization, lifestyle changes, and dietary shifts across the region have contributed to a growing burden of digestive diseases, prompting healthcare systems to prioritize early detection and minimally invasive procedures. In addition, growing awareness among patients and clinicians about the benefits of EUS, along with increased investments in healthcare modernization by both governments and the private sector, is accelerating adoption.

The endoscopic ultrasound industry in Japan is driven by the country’s advanced healthcare system, aging population, and high prevalence of gastrointestinal cancers. Japan has one of the world’s oldest populations, leading to a greater incidence of age-related diseases, including pancreatic, esophageal, and gastric cancers, where endoscopic ultrasound plays a critical role in early detection and precise staging. The country’s well-established medical infrastructure and focus on innovation have supported the widespread integration of advanced EUS systems into clinical practice.

The endoscopic ultrasound industry in China is driven by the combination of factors that includes rising disease burden, healthcare reforms, and technological advancements. The increasing incidence of gastrointestinal cancers and digestive disorders, particularly among the aging population, has increased the demand for advanced diagnostic tools such as EUS. China’s ongoing healthcare reforms, which aim to improve access to high-quality care across urban and rural regions, have further supported the integration of endoscopic ultrasound into hospitals and specialty clinics.

Latin America Endoscopic Ultrasound Market Trends

The endoscopic ultrasound industry in Latin America is driven by improving healthcare infrastructure, rising disease prevalence, and increasing awareness of advanced diagnostic technologies. Countries like Brazil and Argentina are leading this growth, with a growing demand for minimally invasive procedures to diagnose gastrointestinal and pancreatic diseases. In addition, medical tourism is creating further opportunities to adopt endoscopic ultrasound procedures.

The endoscopic ultrasound industry in Brazil is driven by improvements in healthcare infrastructure, rising disease prevalence, and expanding private healthcare services. The country’s large network of both public and private hospitals has been progressively adopting endoscopic ultrasound systems. The growth of private healthcare and medical tourism in Brazil has further fueled investment in cutting-edge technologies, including endoscopic ultrasound.

MEA Endoscopic Ultrasound Market Trends

The endoscopic ultrasound industry in the MEA is witnessing significant growth, driven by improving healthcare systems, rising disease prevalence, and increased investment in medical technologies. Countries like the UAE and Saudi Arabia are at the forefront of adopting advanced diagnostic tools such as EUS, largely due to their strong healthcare infrastructure and government initiatives to modernize healthcare services.

The endoscopic ultrasound industry in Saudi Arabia is experiencing notable growth, driven by the country’s healthcare infrastructure developments and the increasing burden of chronic diseases. Saudi Arabia’s healthcare sector has made significant investments in advanced diagnostic technologies as part of the Vision 2030 initiative, which aims to enhance the quality of healthcare services and improve patient outcomes, which is also expected to fuel the market growth over the forecast period.

Key Endoscopic Ultrasound Company Insights

Key participants in the endoscopic ultrasound industry are implementing numerous initiatives to enhance their market presence and broaden their product reach. Strategies such as product launches, partnerships, and expansions are crucial for driving market growth.

 Recent Developments

• In May 2024, Cook Medical launched the EchoTip AcuCore EUS Biopsy Needle, designed for precision biopsies of gastrointestinal lesions using endoscopic ultrasound (EUS). The needle aims to improve core sample acquisition for accurate diagnosis and staging of challenging-to-reach lesions, enhancing diagnostic yield in EUS-guided procedures.

• In February 2024, Fujifilm India introduced the ALOKA ARIETTA 850 Diagnostic Ultrasound System, with its inaugural installation at Fortis Hospital, Bengaluru. This state-of-the-art endoscopic ultrasound device provides exceptional image quality and an improved user interface, allowing for accurate diagnosis and treatment of gastrointestinal issues. It supports non-invasive procedures, including pancreatic pseudocyst drainage and cancer therapies, to enhance healthcare outcomes in the area.

• In January 2024, EndoSound received 510(k) clearance for its innovative Endoscopic Ultrasound (EUS) technology, designed to enhance diagnostic capabilities in gastrointestinal procedures. This breakthrough device aims to improve the accuracy and efficiency of EUS examinations, potentially leading to better patient outcomes.

Endoscopic Ultrasound Market Report Scope

Global Endoscopic Ultrasound Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic ultrasound market report based on product, application, end use, and region.

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Endoscope

• Ultrasound Probe

• Needle

• Accessories

• Ultrasonic Processors

Application Outlook (Revenue, USD Million, 2018 - 2030)

• Gastrointestinal Cancer

• Lung Cancer

• Pancreaticobiliary Disease

• Others

End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Center

• Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait